Headline
The latest stories from AHA Today.
AHA has released videos, social media posts and other new resources highlighting the importance of patient safety for Patient Safety Awareness Week, March 10-16.
The FBI Internet Crime Complaint Center (IC3) recently reported a record 880,418 internet crime complaints in 2023, including an 18% increase in ransomware complaints to 2,825.
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies through fiscal year 2024, which contains health care provisions of interest to hospitals.
In a letter March 10 to health care providers, the departments of Health and Human Services and Labor called on UnitedHealth Group to expedite payments and provide greater transparency to health care providers impacted by the recent cyberattack on its Change Healthcare unit.
President Biden March 11 submitted to Congress his budget request for fiscal year 2025.
A federal court March 8 vacated the National Labor Relations Board’s 2023 rule for determining joint-employer status under the National Labor Relations Act and reinstated the 2020 rule, agreeing with the U.S. Chamber of Commerce and other plaintiffs that the new rule violates the Administrative…
UnitedHealth Group March 7 announced a series of updates on its response to the unprecedented cyberattack against its subsidiary Change Healthcare.
Jill Howard, R.N., senior consultant, Sheppard Pratt Solutions, is the 2024 chair of AHA’s Committee on Behavioral Health. Zelia Baugh, executive vice president, behavioral health, JPS Health Network (Texas), will serve as the 2024 chair-elect; and Arpan Waghray, M.D., CEO, Well-Being Trust |…
The International Hospital Federation is accepting nominations through April 19 for its 2024 awards honoring excellence in hospitals and health care organizations around the world.
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies for sickle cell disease to apply through May 1 to participate in the Cell and Gene Therapy Access Model.